Leaders in Risk Management

The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training Services for over 30 years.

In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.

Education & Training

DSRU offers a comprehensive range of education and training courses. Find out more or view our complete course calendar.

News News RSS

Hear about the revisions to GVP Module V with the DSRU’s training day

The newly updated GVP Module V now includes clarification of the scope of RMPs in relation to important identified or potential risks and missing information. Join us to hear from speakers including members of the EMA team who wrote the revised GVP Module V and updated the RMP template, as well as QPPV and other pharma staff. The day will include a Question & Answer session with the expert panel of speakers.

The training day will take place on 18th January at the British Medical Association, London. You can find out more and book your place here.

Confirmed speakers: 

  • Emil Cochino, EMA
  • Jane Feron, AstraZeneca
  • Nuria Semis-Costa, EMA
  • Saad Shakir, DSRU
  • Peter de Veene, Grunenthal
  • Phillip Eichorn, Pfizer
View our latest news

Did you know that we can conduct PASS studies in secondary care using our SCEM methodology? Watch this short video to find out how it works:

Our Work - Your Questions

Moving into a career in Pharmacovigilance

The Drug Safety Research Unit (DSRU) offers a range of Pharmacovigilance (PV) training courses suitable for those looking for a career in pharmacovigilance, seeking career progression or in a position that requires PV knowledge and understanding. Depending on specific interests and current knowledge, the team at the DSRU is able to recommend which of our training courses could help […]

View all our latest questions